A single institutional clinical outcome for stages III and IV ovarian cancer patients treated with dose‐dense TC therapy in the frontline or first platinum‐sensitive relapse settingKotaro Sueoka, Norihiro Sugino, Takahiro Sakai et al.|Journal of obstetrics and gynaecology research|2024Cited by 1